Clinical Trials Directory

Trials / Completed

CompletedNCT01064219

Intrauterine Human Chorionic Gonadotrophins (hCG) and Endometrial Treg Cells

The Effect of Intrauterine Injection of Human Chorionic Gonadotrophins (hCG) on the Endometrial T-regulatory Cells and the Electronmicroscopic Endometrial Characteristics

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
The Egyptian IVF-ET Center · Academic / Other
Sex
Female
Age
20 Years – 38 Years
Healthy volunteers
Not accepted

Summary

Intrauterine injection of hCG around the time of implantation may increase endometrial Treg cells and improve implantation. It has been demonstrated that regulatory T cells expand during pregnancy. hCG was found to be secreted by the embryo immediately after fertilization and has chemoattractant properties to Treg cells.

Detailed description

Aim of the work: To study the effect of intrauterine injection of human chorionic gonadotrophin on the endometrial T regulatory cells (Treg cells)and the electromicroscopic endometrial characteristics. Background: It has been demonstrated that regulatory T cells expand during pregnancy and are present at the feto-maternal interface at very early stages in pregnancy. Rational: Intrauterine injection of hCG around the time of implantation may increase endometrial Treg cells and improve implantation. Methods: Intrauterine injection of 100 IU hCG will be done followed by endometrial biopsy to check for Treg cells and pinopodes.

Conditions

Interventions

TypeNameDescription
DRUGhuman chorionic gonadotrophinintrauterine injection of 100 IU hCG followed by endometrial biopsy .

Timeline

Start date
2010-02-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2010-02-08
Last updated
2013-11-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01064219. Inclusion in this directory is not an endorsement.